ICD10 code of Prostate Cancer and ICD9 code

The primary ICD-10-CM code for malignant neoplasm of the prostate is C61, while the corresponding ICD-9-CM code is 185. These diagnostic codes are essential for medical billing, clinical documentation, and tracking the global incidence of prostate cancer within healthcare systems.

What is the clinical significance of Prostate Cancer coding?

Prostate cancer is a significant health concern, with the American Cancer Society estimating it as the most common cancer in men, excluding skin cancer. Using the correct ICD-10 code (C61) ensures that physicians and specialists can accurately document the progression of prostate cancer in electronic health records, which is vital for coordinating multidisciplinary care and insurance coverage.

How is Prostate Cancer diagnosed?

Diagnosis of prostate cancer typically involves a combination of clinical assessments. Early detection often relies on the Prostate-Specific Antigen (PSA) blood test and a digital rectal exam (DRE). If these indicate potential abnormalities, a definitive diagnosis is confirmed through a prostate biopsy, which is then graded using the Gleason score to determine the aggressiveness of the prostate cancer cells.

What factors influence the management of Prostate Cancer?

The treatment trajectory for prostate cancer depends on the stage, risk category, and the patient's overall health. Management strategies commonly include:

• Active Surveillance: Closely monitoring low-risk prostate cancer with periodic PSA tests and biopsies.


• Surgical Intervention: Radical prostatectomy to remove the prostate gland.


• Radiation Therapy: Utilizing external beam radiation or brachytherapy to target cancerous tissue.


• Hormonal Therapy: Medications designed to lower androgen levels, as these hormones can fuel prostate cancer growth.

Next steps

• Consult a urologist or an oncologist to discuss your specific PSA levels and biopsy results.


• Join the community of 15 members on DiseaseMaps.org who are navigating their own experiences with prostate cancer.


• Inquire with your care team about participating in clinical trials if you are seeking the latest advancements in treatment.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment; always seek the advice of your physician regarding any medical condition.

References

• National Cancer Institute (NCI) - Prostate Cancer Overview


• ICD-10-CM/PCS Resources (CMS.gov)


• American Cancer Society - Prostate Cancer Section


• NIH National Library of Medicine (MedlinePlus)